logo
Share SHARE
FONT-SIZE Plus   Neg

Boston Scientific Begins Trial To Study Neurostimulation For Migraine Treatment

Boston Scientific Corporation(BSX), a maker of medical devices, Friday said it launched a clinical trial, OPTIMISE, to find out if occipital nerve stimulation or ONS using the Precision System can safely and effectively treat chronic migraine when used in conjunction with anti-migraine medications. The multi-center, randomized, placebo-controlled study is expected to be used to support various regulatory approvals of this novel therapy for chronic migraine.

With ONS, a small programmable implanted device sends electrical impulses to the greater occipital nerve, which runs from the top of the spinal cord to the base of the scalp. The Precision System for chronic migraine is investigational and is currently available as an approved treatment in the U.S., Canada, Europe and Australia as an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome and intractable low back pain and leg pain.

"We believe that the Boston Scientific neurostimulation therapy for migraine has enormous potential to help migraine sufferers worldwide..." said Maulik Nanavaty, president, Neuromodulation, Boston Scientific.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
HP launched a new slim Chromebook 11 G5 with a touchscreen. It will hit the market in October. Dow Chemical Co. announced a series of actions to achieve synergy capture from the restructuring of its ownership of the Dow Corning Corporation. The collective actions will result in a reduction of approximately 2,500 positions globally, or approximately four percent of Dow's workforce. South Korea's Fair Trade Commission or FTC is investigating Apple over some matters related to the tech giant in that country, Reuters reported, citing the head of the anti-competition body. FTC Chairman Jeong Jae-chan talked about the investigation during a parliamentary hearing on Tuesday, but has not disclosed further details.
comments powered by Disqus
Follow RTT